Items where authors include "Eriksson, M."

Article

Yiangou, K., Mavaddat, N., Dennis, J. et al. (124 more authors) (2024) Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction. Breast Cancer Research, 26. 189. ISSN 1465-5411

Bayona-Valderrama, Á, Gunnarsdóttir, M.J., Rossi, P.M. et al. (12 more authors) (2024) Water quality for citizen confidence: The implementation process of 2020 EU Drinking Water Directive in Nordic countries. Water Policy, 26 (8). pp. 793-816. ISSN 1366-7017

Gunnarsdottir, M.J., Gardarsson, S.M., Eriksson, M. et al. (12 more authors) (2023) Implementing risk-based approaches to improve drinking water quality in small water supplies in the Nordic region – barriers and solutions. Journal of Water and Health, 21 (12). pp. 1747-1760. ISSN 1477-8920

Levi, H., Carmi, S., Rosset, S. et al. (135 more authors) (2023) Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel. Journal of Medical Genetics, 60 (12). ISSN 0022-2593

Wichert, K. orcid.org/0000-0001-7708-7843, Hoppe, R., Ickstadt, K. et al. (45 more authors) (2023) Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer. European Journal of Epidemiology, 38. pp. 1053-1068. ISSN 0393-2990

Middha, P., Wang, X., Behrens, S. et al. (129 more authors) (2023) A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry. Breast Cancer Research, 25. 93.

Morra, A. orcid.org/0000-0003-4983-7883, Schreurs, M.A.C. orcid.org/0000-0002-1826-5344, Andrulis, I.L. et al. (114 more authors) (2023) Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival. Cancer Medicine, 12 (15). pp. 16142-16162. ISSN 2045-7634

Dixon-Suen, S.C. orcid.org/0000-0003-3714-8386, Lewis, S.J., Martin, R.M. et al. (155 more authors) (2022) Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study. British Journal of Sports Medicine, 56 (20). pp. 1157-1170. ISSN 0306-3674

Escala-Garcia, M., Guo, Q., Dörk, T. et al. (234 more authors) (2019) Genome-wide association study of germline variants and breast cancer-specific mortality. British Journal of Cancer, 120. pp. 647-657. ISSN 0007-0920

Colombo, M., Lopez-Perolio, I., Meeks, H.D. et al. (112 more authors) (2018) The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. Human Mutation, 39 (5). pp. 729-741. ISSN 1059-7794

Guo, Q., Burgess, S., Turman, C. et al. (132 more authors) (2017) Body mass index and breast cancer survival: a Mendelian randomization analysis. International Journal of Epidemiology, 46 (6). pp. 1814-1822. ISSN 0300-5771

Jiao, X., Aravidis, C., Marikkannu, R. et al. (103 more authors) (2017) PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. Oncotarget, 8. pp. 102769-102782. ISSN 1949-2553

Ghoussaini, M, French, J.D., Michailidou, K. et al. (122 more authors) (2016) Evidence that the 5p12 variant rs10941679 confers susceptibility to estrogen receptor positive breast cancer through FGF10 and MRPS30 regulation. American Journal of Human Genetics, 99 (4). pp. 903-911. ISSN 0002-9297

Hollestelle, A., van der Baan, F.H., Berchuck, A. et al. (355 more authors) (2016) No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology, 141 (2). pp. 386-401. ISSN 0090-8258

Easton, D.F., Lesueur, F., Decker, B. et al. (126 more authors) (2016) No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. Journal of Medical Genetics . ISSN 0022-2593

Hamdi, Y., Soucy, P., Adoue, V. et al. (93 more authors) (2016) Association of Breast Cancer Risk with Genetic Variants Showing Differential Allelic Expression: Identification of a Novel Breast Cancer Susceptibility Locus at 4q21. Oncotarget, 7. pp. 80140-80163. ISSN 1949-2553

Orr, N., Dudbridge, F., Dryden, N. et al. (213 more authors) (2015) Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. Human Molecular Genetics, 24 (10). 2966 - 2984. ISSN 0964-6906

Guo, Q., Schmidt, M.K., Kraft, P. et al. (143 more authors) (2015) Identification of Novel Genetic Markers of Breast Cancer Survival. Journal of the National Cancer Institute, 107 (5). ISSN 0027-8874

Mavaddat, N., Pharoah, P.D.P., Michailidou, K. et al. (209 more authors) (2015) Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants. JNCI-Journal of the National Cancer Institute, 107 (5). ISSN 0027-8874

Pirie, A., Guo, Q., Kraft, P. et al. (146 more authors) (2015) Common germline polymorphisms associated with breast cancer-specific survival. Breast Cancer Research, 17. 58. ISSN 1465-5411

Michailidou, K., Beesley, J., Lindstrom, S. et al. (245 more authors) (2015) Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nature Genetics, 47. pp. 373-380. ISSN 1061-4036

Milne, R.L., Burwinkel, B., Michailidou, K. et al. (178 more authors) (2014) Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium. Human Molecular Genetics, 23 (22). pp. 6096-6111. ISSN 0964-6906

Khan, S., Greco, D., Michailidou, K. et al. (161 more authors) (2014) MicroRNA Related Polymorphisms and Breast Cancer Risk. PLOS ONE, 9 (11). e109973. ISSN 1932-6203

Agarwal, D., Pineda, S., Michailidou, K. et al. (179 more authors) (2014) FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium. British Journal of Cancer, 110 (4). pp. 1088-1100. ISSN 0007-0920